112 related articles for article (PubMed ID: 2987368)
1. Systemic lymphoid atrophy in coxsackievirus B3-infected mice: effects of virus and immunopotentiating agents.
Matteucci D; Toniolo A; Conaldi PG; Basolo F; Gori Z; Bendinelli M
J Infect Dis; 1985 Jun; 151(6):1100-8. PubMed ID: 2987368
[TBL] [Abstract][Full Text] [Related]
2. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
3. Impairment of immunocompetent mouse spleen cell functions by infection with coxsackievirus B3.
Bendinelli M; Matteucci D; Toniolo A; Patanè AM; Pistillo MP
J Infect Dis; 1982 Dec; 146(6):797-805. PubMed ID: 6292311
[TBL] [Abstract][Full Text] [Related]
4. Changed distribution and immune effects of nickel augment viral-induced inflammatory heart lesions in mice.
Ilbäck NG; Fohlman J; Friman G
Toxicology; 1994 Jul; 91(2):203-19. PubMed ID: 8059443
[TBL] [Abstract][Full Text] [Related]
5. The influence of quantitated post-weaning undernutrition on coxsackievirus B3 infection of adult mice. II. Alteration of host defense mechanisms.
Woodruff JF
J Infect Dis; 1970 Feb; 121(2):164-81. PubMed ID: 5414399
[No Abstract] [Full Text] [Related]
6. The effects of pre-existing coxsackievirus B4 myocardial disease on the expression of coxsackievirus B3 myocarditis.
Khatib R; Reyes MP; Khatib G; Giraldo A
Can J Cardiol; 1993 Jun; 9(5):444-7. PubMed ID: 8394194
[TBL] [Abstract][Full Text] [Related]
7. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity.
Lamontagne L; Descoteaux JP; Jolicoeur P
J Immunol; 1989 Jun; 142(12):4458-65. PubMed ID: 2542412
[TBL] [Abstract][Full Text] [Related]
8. Coxsackievirus B4 infection alters thymic, splenic, and peripheral lymphocyte repertoire preceding onset of hyperglycemia in mice.
Chatterjee NK; Hou J; Dockstader P; Charbonneau T
J Med Virol; 1992 Oct; 38(2):124-31. PubMed ID: 1334127
[TBL] [Abstract][Full Text] [Related]
9. Role of interferon in lethality and lymphoid atrophy induced by Coxsackievirus B3 infection in mice.
Capobianchi MR; Matteucci D; Giovannetti A; Soldaini E; Bendinelli M; Stanton JG; Dianzani F
Viral Immunol; 1991; 4(2):103-10. PubMed ID: 1722097
[TBL] [Abstract][Full Text] [Related]
10. The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease.
Hashimoto I; Tatsumi M; Nakagawa M
Br J Exp Pathol; 1983 Oct; 64(5):497-504. PubMed ID: 6315043
[TBL] [Abstract][Full Text] [Related]
11. Coxsackievirus infection of mice. II. Viral kinetics and histopathological changes in mice experimentally infected with coxsackievirus B3 by intraperitoneal route.
Vargová A; Bopegamage S; Borsanyiová M; Petrovicová A; Benkovicová M
Acta Virol; 2003; 47(4):253-7. PubMed ID: 15068381
[TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus infection of mice. I. Viral kinetics and histopathological changes in mice experimentally infected with coxsackieviruses B3 and B4 by oral route.
Bopegamage S; Borsanyiová M; Vargová A; Petrovicová A; Benkovicová M; Gomolcák P
Acta Virol; 2003; 47(4):245-51. PubMed ID: 15068380
[TBL] [Abstract][Full Text] [Related]
13. Prevention of murine coxsackie B3 viral myocarditis and associated lymphoid organ atrophy with recombinant human leucocyte interferon alpha A/D.
Kishimoto C; Crumpacker CS; Abelmann WH
Cardiovasc Res; 1988 Oct; 22(10):732-8. PubMed ID: 2855719
[TBL] [Abstract][Full Text] [Related]
14. Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine Coxsackievirus B3 myocarditis.
Ilbäck NG; Fohlman J; Slorach S; Friman G
J Immunol; 1989 May; 142(9):3225-8. PubMed ID: 2540239
[TBL] [Abstract][Full Text] [Related]
15. An enterovirus-induced murine model of an acute dilated-type cardiomyopathy.
Reyes MP; Smith FE; Lerner AM
Intervirology; 1984; 22(3):146-55. PubMed ID: 6094387
[TBL] [Abstract][Full Text] [Related]
16. The role of B lymphocytes in coxsackievirus B3 infection.
Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
[TBL] [Abstract][Full Text] [Related]
17. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
[TBL] [Abstract][Full Text] [Related]
19. Effects of the antiviral WIN 54954 and the immune modulator LS 2616 on cachectin/TNF and gamma-interferon responses during viral heart disease.
Ilbäck NG; Wesslén L; Pauksen K; Stålhandske T; Friman G; Fohlman J
Scand J Infect Dis Suppl; 1993; 88():117-23. PubMed ID: 8390714
[TBL] [Abstract][Full Text] [Related]
20. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.
Woodruff JF; Woodruff JJ
J Immunol; 1974 Dec; 113(6):1726-34. PubMed ID: 4610045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
